Corticotropin therapy in patients with myasthenia gravis: steroid metabolism, and histology of skeletal muscle and thymus.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D015068:17-Ketosteroids / Q000097:blood / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000378:metabolism* / Q000473:pathology; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000473:pathology; D012141:Respiratory Tract Infections / Q000652:urine; D012712:Serum Globulins / Q000378:metabolism; D013950:Thymus Gland / Q000378:metabolism* / Q000473:pathology; D014436:Typhoid-Paratyphoid Vaccines
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D012712:Serum Globulins; D014436:Typhoid-Paratyphoid Vaccines; D000324:Adrenocorticotropic Hormone